Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Nonmedical use of prescription opioids: motive and ubiquity issues.

Zacny JP, Lichtor SA.

J Pain. 2008 Jun;9(6):473-86. doi: 10.1016/j.jpain.2007.12.008. Epub 2008 Mar 14. Review.

2.

The burden of the nonmedical use of prescription opioid analgesics.

Gilson AM, Kreis PG.

Pain Med. 2009 Jul;10 Suppl 2:S89-100. doi: 10.1111/j.1526-4637.2009.00668.x. Review.

3.

National drug control policy and prescription drug abuse: facts and fallacies.

Manchikanti L.

Pain Physician. 2007 May;10(3):399-424. Review.

5.

College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement.

Zacny J, Bigelow G, Compton P, Foley K, Iguchi M, Sannerud C.

Drug Alcohol Depend. 2003 Apr 1;69(3):215-32. Review.

PMID:
12633908
6.

Prescription opioid related misuse, harms, diversion and interventions in Canada: a review.

Fischer B, Argento E.

Pain Physician. 2012 Jul;15(3 Suppl):ES191-203. Review.

7.

Opioid epidemic in the United States.

Manchikanti L, Helm S 2nd, Fellows B, Janata JW, Pampati V, Grider JS, Boswell MV.

Pain Physician. 2012 Jul;15(3 Suppl):ES9-38. Review.

8.

The prevalence of mental health and pain symptoms in general population samples reporting nonmedical use of prescription opioids: a systematic review and meta-analysis.

Fischer B, Lusted A, Roerecke M, Taylor B, Rehm J.

J Pain. 2012 Nov;13(11):1029-44. doi: 10.1016/j.jpain.2012.07.013. Epub 2012 Oct 3. Review.

PMID:
23040158
9.

Challenges in the development of prescription opioid abuse-deterrent formulations.

Katz NP, Adams EH, Chilcoat H, Colucci RD, Comer SD, Goliber P, Grudzinskas C, Jasinski D, Lande SD, Passik SD, Schnoll SH, Sellers E, Travers D, Weiss R.

Clin J Pain. 2007 Oct;23(8):648-60. Review.

PMID:
17885342
10.

Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain.

Webster L, St Marie B, McCarberg B, Passik SD, Panchal SJ, Voth E.

J Opioid Manag. 2011 May-Jun;7(3):235-45. Review.

PMID:
21823554
11.

Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.

PMID:
18503626
12.

The availability, diversion and injection of pharmaceutical opioids in South Asia.

Larance B, Ambekar A, Azim T, Murthy P, Panda S, Degenhardt L, Mathers B.

Drug Alcohol Rev. 2011 May;30(3):246-54. doi: 10.1111/j.1465-3362.2011.00304.x. Review.

PMID:
21545554
13.

US Food and Drug Administration's Risk Evaluation and Mitigation Strategy for extended-release and long-acting opioids: pros and cons, and a European perspective.

Mercadante S, Craig D, Giarratano A.

Drugs. 2012 Dec 24;72(18):2327-32. doi: 10.2165/11642230-000000000-00000. Review.

PMID:
23116252
14.

Prevalence of pain among nonmedical prescription opioid users in substance use treatment populations: systematic review and meta-analyses.

Lusted A, Roerecke M, Goldner E, Rehm J, Fischer B.

Pain Physician. 2013 Nov-Dec;16(6):E671-84. Review.

17.

Prescription drug abuse: from epidemiology to public policy.

McHugh RK, Nielsen S, Weiss RD.

J Subst Abuse Treat. 2015 Jan;48(1):1-7. doi: 10.1016/j.jsat.2014.08.004. Epub 2014 Aug 28. Review.

Items per page

Supplemental Content

Write to the Help Desk